HAX1 has been found to be overexpressed in breast cancer, lung cancer, and melanoma [27, 28], although the exact molecular mechanism by which overexpression of HAX1 may provide an oncogenic role needs to be evaluated. The gene discussed is HAX1; the disease is breast cancer.